The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Kelly Thomas Patrick

Reporting owner CIK 0001410514 · Chief Financial Officer

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Kelly Thomas PatrickKelly Thomas PatrickKelly Thomas Patrick · October 15, 2026 · Exercise / conversion · Common SharesKelly Thomas Patrick · September 30, 2026 · Purchase · Common SharesKelly Thomas Patrick · October 15, 2025 · Stock award · Restricted Share UnitsKelly Thomas Patrick · October 15, 2025 · Stock award · Share Option (Right to Buy)Oct 15, 2025Oct 15, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 15, 2026Xenon Pharmaceuticals Inc.Common SharesKelly Thomas PatrickExercise / conversion
Sep 30, 2026Xenon Pharmaceuticals Inc.Common SharesKelly Thomas PatrickPurchase
Oct 15, 2025Xenon Pharmaceuticals Inc.Restricted Share UnitsKelly Thomas PatrickStock award
Oct 15, 2025Xenon Pharmaceuticals Inc.Share Option (Right to Buy)Kelly Thomas PatrickStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Xenon Pharmaceuticals Inc.XENE · company listings
Kelly Thomas PatrickChief Financial Officer
Exercise / conversionCommon SharesNon-derivative security · Code M7,500Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xenon Pharmaceuticals Inc.XENE · company listings
Kelly Thomas PatrickChief Financial Officer
PurchaseCommon SharesNon-derivative security · Code P15,00037.316Value: 559,740Currency not specifiedView ↗
Trade: Xenon Pharmaceuticals Inc.XENE · company listings
Kelly Thomas PatrickChief Financial Officer
Stock awardRestricted Share UnitsDerivative security · Code A30,0000Value: 0Currency not specifiedView ↗
Trade: Xenon Pharmaceuticals Inc.XENE · company listings
Kelly Thomas PatrickChief Financial Officer
Stock awardShare Option (Right to Buy)Derivative security · Code A225,0000Value: 0Currency not specifiedView ↗